Healthcare [ 7/13 ] | Health Information Services [ 90/163 ]
NASDAQ | Common Stock
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies.
The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases.
It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization.
The company was founded in 2011 and is headquartered in Boston, Massachusetts.
As of July 1, 2024, Akili, Inc. operates as a subsidiary of Virtual Therapeutics Corp.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 9, 24 | 0.00 Increased by +100.00% | -0.17 Increased by +100.00% |
| Feb 29, 24 | -0.14 Increased by +80.24% | -0.21 Increased by +32.24% |
| Nov 9, 23 | -0.18 Decreased by -123.68% | -0.19 Increased by +5.26% |
| Aug 10, 23 | -0.16 Increased by +56.27% | -0.20 Increased by +20.00% |
| May 11, 23 | -0.21 Decreased by -62.69% | -0.22 Increased by +3.86% |
| Mar 7, 23 | -0.72 Decreased by -1.10 K% | -0.31 Decreased by -132.26% |
| Nov 10, 22 | 0.76 Increased by +7.70 K% | -0.25 Increased by +404.00% |
| Aug 12, 22 | -0.37 Decreased by -3.56 K% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 749.00 K Increased by +574.77% | -11.15 M Increased by +33.71% | Decreased by -1.49 K% Increased by +90.18% |
| Sep 30, 23 | 702.00 K Increased by +756.10% | -15.88 M Decreased by -112.08% | Decreased by -2.26 K% Decreased by -101.41% |
| Jun 30, 23 | 114.00 K Increased by +78.13% | -11.76 M Increased by +47.63% | Decreased by -10.31 K% Increased by +70.60% |
| Mar 31, 23 | 113.00 K Increased by +71.21% | -22.93 M Decreased by -4.96% | Decreased by -20.29 K% Increased by +38.70% |
| Dec 31, 22 | 111.00 K Decreased by -31.06% | -16.82 M Increased by +14.26% | Decreased by -15.15 K% Decreased by -24.37% |
| Sep 30, 22 | 82.00 K Decreased by -47.10% | 131.47 M Increased by +824.89% | Increased by +160.33 K% Increased by +1.47 K% |
| Jun 30, 22 | 64.00 K Increased by +N/A% | -22.45 M Decreased by -15.70 M% | Decreased by -35.08 K% - |
| Mar 31, 22 | 66.00 K Increased by +N/A% | -21.84 M Decreased by N/A% | Decreased by -33.09 K% - |